Healthcare

ResMed Inc. (ASX:RMD)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Equipment & Supplies

Market Price : AUD 33.16-1.54 (4.438%)

(as on 2022-01-19 20:57:14 AEDT)

Market Cap : AUD 48.322 B

Dividend Yield (Annualized) : 0.630%

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
34.7 33.57 33.16 33.160L 33.600 H 23.480L 40.790 H
Last Trade 33.16
Change% -4.4380
52 W H/L 40.790/23.480
EBITDA 1.142 B
NPAT After Abnormal Items 631.159 M
Equity 3.838 B
ROE% 16.93%
Total Liabilities 2.451 B
Total Revenue 4.273 B
Cash and Cash Equivalents 392.761 M

Stock Information

Share price 33.16
Market Cap 48.322 B
Price/Gross Cash Flow 42.89
Dividend Yield Excluding Special 0.65%
Ending Shares 1.456 B
52-Week Range 40.790-23.480
P/E ratio 73.529
Sector P/E --
EPS 43.10
EV/EBITDA 32.69
Net Profit Margin (%) 15.28%
Gross Cash Flows Per Share 0.76
Net Gearing 17.27%
Gross DPS (AUD) 0.2136
Gross Dividend Yield (Annualized) 0.65%
Earnings Yield 1.360
Net Tangible Asset (NTA) 0.52
Sales Per Share 2.90
Book Value Per Share 2.64

Announcements

Heading Date/Time
Update - Dividend/Distribution - RMD  12/11/2021 1:50PM
Statement of CDIs on issue - RMD  05/11/2021 10:09AM
FORM 10Q For Qtr ended September, 2021  01/11/2021 9:22AM
Dividend/Distribution - RMD  29/10/2021 8:17AM
ResMed Announces Results for the First Quarter of FY2022  29/10/2021 8:16AM
RMD to Report First Quarter Fiscal 2022 Results  11/10/2021 9:49AM
Form 8-K/A Departure of Directors or Certain Officers  08/10/2021 9:18AM
Notice of Annual General Meeting Additional Materials  07/10/2021 8:23AM
Notice of Annual General Meeting/Proxy Form  07/10/2021 8:22AM
Statement of CDIs on issue - RMD  05/10/2021 11:50AM
Form 8-K Amended and Restated Bylaws  14/09/2021 9:43AM
S&P DJI Announces September 2021 Quarterly Rebalance  03/09/2021 5:10PM
Statement of CDIs on issue - RMD  03/09/2021 2:07PM
Update - Dividend/Distribution - RMD  23/08/2021 10:05AM
Form 10-K/A - Amendment No. 1  20/08/2021 8:08AM
Resmed Form 10-K Annual Report  18/08/2021 8:21AM
Dividend/Distribution - RMD  06/08/2021 8:18AM
ResMed Announces Results for the Fourth Quarter of FY2021  06/08/2021 8:17AM
Statement of CDIs on issue - RMD  05/08/2021 9:07AM
RMD to Report Fourth Quarter Fiscal 2021 Results  16/07/2021 8:23AM
Statement of CDIs on issue - RMD  07/07/2021 5:09PM
Chess Depositary Interest - RMD  04/06/2021 11:41AM
FORM SD  27/05/2021 2:15PM
FORM S-8  24/05/2021 9:29AM
Update - Dividend/Distribution - RMD  14/05/2021 2:08PM
Chess Depositary Interest - RMD  06/05/2021 10:21AM
FORM 10Q For Qtr ended March, 2021  03/05/2021 9:07AM
Dividend/Distribution - RMD  30/04/2021 8:10AM
ResMed Announces Results for the Third Quarter of FY2021  30/04/2021 8:10AM

Similar Companies

Related Articles

About Company

ResMed Inc (ASX: RMD) is a health care company, which is a medical device manufacturing company particularly. The company is based out of San Diego, United States of America. The most recent acquisition announced by the company was in May 2018 when it acquired Healthcarefirst Inc. It is a leading cloud-connected devices health company. The group has over 5 million cloud-connected devices and these assist patients in daily remote patient monitoring and other requirements and has emerged as a global leader in remote monitoring software.

Corporate Information

company address 9001 Spectrum Center Blvd, SAN DIEGO, CA, UNITED STATES OF AMERICA, 92123

company phone+612 8884 1000

company websitehttp://www.resmed.com

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/06/2021 0% 0.214 0.65%
30/06/2020 0% 0.229 0.83%
30/06/2019 0% 0.214 1.24%
30/06/2018 0% 0.188 1.33%
30/06/2017 0% 0.175 1.75%
30/06/2016 0% 0.168 2.03%
30/06/2015 0% 0.145 1.99%
30/06/2014 0% 0.112 2.05%
30/06/2013 0% 0.078 1.56%
30/06/2012 0% 0.017 0.54%

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-17 2022
Report (Annual) 2022-03-30 2022

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 4.252 B 3.792 B 3.717 B 3.166 B 2.687 B
Other Revenue 20.709 M 516.73 M 0 0 5.325 M
Total Revenue 4.273 B 4.309 B 3.717 B 3.166 B 2.692 B
Interest Income 481,511 1.488 M 3.278 M 22.159 M 22.211 M
Interest Expenses -31.909 M -58.833 M -51.556 M -38.364 M -36.708 M
Expenses -2.793 B -2.945 B -2.616 B -2.071 B -1.884 B
EBITDA 1.48 B 1.364 B 1.101 B 1.096 B 808.006 M
Depreciation and Amortization -254.746 M -225.63 M -215.022 M -162.306 M -206.364 M
Depreciation -153.383 M -109.508 M -108.166 M -99.549 M -145.81 M
Amortisation -101.363 M -116.123 M -106.856 M -62.756 M -60.554 M
EBIT 1.225 B 1.138 B 885.614 M 933.212 M 601.642 M
Pre Tax Profit 1.194 B 1.081 B 837.336 M 917.007 M 587.145 M
Tax Expense -544.236 M -162.34 M -174.195 M -285.25 M -99.401 M
Net Profit After Tax 649.654 M 918.219 M 663.141 M 631.758 M 487.744 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items -18.496 M -12.385 M -86.224 M -204.768 M -42.757 M
Reported Net Profit After Abnormal Items 631.159 M 905.834 M 576.917 M 426.99 M 444.987 M
Ending Shares 1.456 B 1.449 B 1.437 B 1.427 B 1.422 B
Weighted Average Shares 1.465 B 1.457 B 1.445 B 1.44 B 1.425 B
EPS After Abnormal Items (cents) 43.1 62.19 39.93 29.65 31.24
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 2.095 B 2.22 B 1.633 B 1.442 B 2.137 B
Total Non Current Assets 4.194 B 4.464 B 4.224 B 2.704 B 2.372 B
Total Assets 6.289 B 6.684 B 5.857 B 4.145 B 4.509 B
Total Current Liabilities 1.213 B 878.276 M 792.801 M 691.718 M 468.183 M
Total Non Current Liabilities 1.238 B 2.168 B 2.11 B 667.966 M 1.493 B
Total Liabilities 2.451 B 3.046 B 2.902 B 1.36 B 1.961 B
Net Assets 3.838 B 3.638 B 2.955 B 2.786 B 2.548 B
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash 979.939 M 1.169 B 654.572 M 683.299 M 538.29 M
Net Invested Cash -210.777 M -262.073 M -1.534 B -137.768 M -106.461 M
Net Financing Cash Flows -1.017 B -462.314 M 827.952 M -1.389 B -341.741 M
Beginning Cash 616.063 M 214.379 M 269.073 M 1.112 B 950.902 M
End Cash Position 392.761 M 674.859 M 209.793 M 255.312 M 1.069 B
Exchange Rate Adjustments 24.605 M 15.911 M -7.93 M -13.181 M 27.568 M
Other Cash Adjustments 0 0 0 0 0
Ending Cash 392.761 M 674.859 M 209.793 M 255.312 M 1.069 B

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK